2X7 Stock Overview
A medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
OrthoPediatrics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$21.00 |
| 52 Week High | US$32.40 |
| 52 Week Low | US$21.00 |
| Beta | 1.16 |
| 11 Month Change | -15.32% |
| 3 Month Change | -16.67% |
| 1 Year Change | -26.06% |
| 33 Year Change | -61.82% |
| 5 Year Change | -39.61% |
| Change since IPO | -40.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2X7 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -17.3% | -4.5% | -0.6% |
| 1Y | -26.1% | -3.2% | 9.6% |
Return vs Industry: 2X7 underperformed the German Medical Equipment industry which returned -3.2% over the past year.
Return vs Market: 2X7 underperformed the German Market which returned 9.6% over the past year.
Price Volatility
| 2X7 volatility | |
|---|---|
| 2X7 Average Weekly Movement | 8.5% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2X7's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 2X7's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 247 | David Bailey | www.orthopediatrics.com |
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti.
OrthoPediatrics Corp. Fundamentals Summary
| 2X7 fundamental statistics | |
|---|---|
| Market cap | €521.93m |
| Earnings (TTM) | -€27.02m |
| Revenue (TTM) | €180.17m |
2.9x
P/S Ratio-19.5x
P/E RatioIs 2X7 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2X7 income statement (TTM) | |
|---|---|
| Revenue | US$189.67m |
| Cost of Revenue | US$49.93m |
| Gross Profit | US$139.75m |
| Other Expenses | US$168.19m |
| Earnings | -US$28.44m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.17 |
| Gross Margin | 73.68% |
| Net Profit Margin | -15.00% |
| Debt/Equity Ratio | 19.6% |
How did 2X7 perform over the long term?
See historical performance and comparison